This inventor holds 1 USPTO granted patent and 2 published patent applications and 2 EPO patents. Top assignee: Rhein Biotech Gesellschaft Fur Neue Biotechnologische Prozesse Und Produkte Mbh. Active years: 2003.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003
Title: The Innovative Contributions of Karl Melber
Introduction
Karl Melber is a notable inventor based in Düsseldorf, Germany. He has made significant contributions to the field of medical technology, particularly in the area of blood testing. His innovative approach has the potential to enhance the efficiency and accuracy of blood analysis.
Latest Patents
Karl Melber holds a patent for a method of carrying out blood tests. This invention is based on the discovery that clinico-chemical blood parameters can be determined using both blood serum and blood plasma. The method allows for freshly taken blood samples, mixed with at least one thrombin inhibitor, to be used for determining both clinico-chemical and hematological parameters. This advancement eliminates the need for separating coagulable components, streamlining the testing process.
Career Highlights
Karl Melber is associated with Rhein Biotech Gesellschaft für Neue Biotechnologische Prozesse und Produkte mbH, where he applies his expertise in biotechnology. His work focuses on developing innovative solutions that improve medical testing methodologies.
Collaborations
Some of his notable coworkers include Alexander W. M. Strasser and Hans Menssen, who contribute to the collaborative efforts in advancing biotechnological processes.
Conclusion
Karl Melber's contributions to blood testing technology exemplify the impact of innovation in the medical field. His patent reflects a significant step forward in enhancing the efficiency of blood analysis, showcasing the importance of inventive thinking in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile